Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily

While bivalent and quadrivalent HPV vaccines have been used for about 10 years, a nonavalent vaccine against HPV types 6/11/16/18/31/33/45/52 and 58 has been recently approved by FDA and EMA and is now commercially available. The objective of our study was to evaluate the potential impact of the non...

Descripción completa

Detalles Bibliográficos
Autores principales: Capra, Giuseppina, Giovannelli, Lucia, Matranga, Domenica, Bellavia, Carmelina, Guarneri, Maria Francesca, Fasciana, Teresa, Scaduto, Giovanna, Firenze, Alberto, Vassiliadis, Alessandra, Perino, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557238/
https://www.ncbi.nlm.nih.gov/pubmed/28594305
http://dx.doi.org/10.1080/21645515.2017.1319026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557238/
https://www.ncbi.nlm.nih.gov/pubmed/28594305
http://dx.doi.org/10.1080/21645515.2017.1319026

Ejemplares similares